What is CustoMED?
Founded in 2018 and originating from Sheba Medical Center's 3D Printing & Innovation Lab, CustoMED operates as a surgeon-first platform. The company leverages artificial intelligence and advanced 3D printing technologies to create patient-specific surgical guides and implants. This approach aims to precisely tailor surgical interventions to individual patient anatomy, thereby enhancing surgical outcomes and efficiency in orthopedic procedures. CustoMED's core mission is to automate and optimize the translation of surgeons' decisions into tangible, personalized surgical tools.
How much funding has CustoMED raised?
CustoMED has raised a total of $6M across 1 funding round:
Seed
$6M
Seed (2025): $6M with participation from Longevity Venture Partners, Varana Capital, and Israel Innovation Authority
Key Investors in CustoMED
Longevity Venture Partners
Longevity Venture Partners is an early-stage venture capital firm focused on supporting entrepreneurs in the Silvertech, Healthcare, and Wellness sectors. The firm aims to accelerate the growth of its portfolio companies on a global scale by utilizing its commercial ecosystem and international network of experts.
Varana Capital
Varana Capital is a Denver-based investment firm specializing in pre-seed through series A technology investments, primarily focused on asset-light deep-tech. The company offers more than just capital, leveraging its experience, expertise, and networks to assist partner companies in overcoming challenges.
Israel Innovation Authority
The Innovation Authority is responsible for driving, investing in, and developing Israel's technological innovation. It supports entrepreneurs, startups, large companies, researchers, and students with innovative ideas, helping them turn visions into reality.
What's next for CustoMED?
The recent major strategic investment positions CustoMED for accelerated growth and further development of its AI-powered platform. This substantial capital infusion is expected to fuel advancements in its technology, expand its market reach, and potentially enhance its research and development capabilities. The company's focus on patient-specific solutions within the orthopedic surgery sector, combined with its enterprise-level backing, suggests a strategic push towards broader adoption and integration into clinical workflows, solidifying its role as a key innovator in medical technology.
See full CustoMED company page
